The Venture Codex Logo

The Venture Codex

Innoviva

1350 Old Bayshore Hwy Suite 400, Burlingame, CA, 94010, United States

Overview

Partnering to advance innovative therapies and improve patient care.

Founded

1996

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

United States

Sector focus

Biotechnology
Financial Services
Pharmaceutical

Investment portfolio

3rounds
NAMEDATESIZE
Beacon Biosignals
Apr 2026Participated
$11 MSeries B
Beacon Biosignals
Nov 2025Participated
$86 MSeries B
InCarda Therapeutics
Oct 2020Led
$30 MSeries C
Beacon Biosignals
Apr 2026Participated
$11 MSeries B
Beacon Biosignals
Nov 2025Participated
$86 MSeries B
InCarda Therapeutics
Oct 2020Led
$30 MSeries C
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Innoviva: 3 funding rounds are recorded in the selected participation categories.All available history.
Innoviva: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B02
Series C+10

Monthly Deal Activity

Innoviva: 3 deals are recorded across 73 months.All available history.
Innoviva: 3 deals are recorded across 73 months. All available history
MonthDeals
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Innoviva: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Innoviva: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Hardware & Robotics2
AI & Machine Learning2

Deal Size Distribution

Innoviva: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Innoviva: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Innoviva: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Innoviva: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Innoviva: 16 co-investors are shown, with Casdin Capital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Innoviva: 16 co-investors are shown, with Casdin Capital sharing 2 recorded deals. All available history
Co-investorShared deals
Casdin Capital2
Catalio Capital Management2
General Catalyst2
Google Ventures2
Indicator Ventures2
Logos Capital2
Section 322
Deerfield Management1
HealthCap1
JSL Health1
Kicker Ventures1
Morningside1
Nexus NeuroTech Ventures1
Palo Santo1
Samsung Next1
Takeda1

Investment Strategy

Innoviva: Led accounts for 33% and participating for 67% of round participation.All available history.
Innoviva: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
Innoviva: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Innoviva: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

George B. Abercrombie

Senior Vice President and Chief Commercial Officer

Pavel Raifeld

CEO

Stephen Basso

Chief Financial Officer